«Ricondurre gli uomini alla ragione e alla morale»: Condorcet e Voltaire a confronto

The text reproduces the introductory essay to Condocert, Vita di Voltaire, edited by Marco Armandi, Roma, Editori Riuniti, 1999, p. 7-47

A Facile and Green Synthesis of a MoO2-Reduced Graphene Oxide Aerogel for Energy Storage Devices

A simple, low cost, and "green" method of hydrothermal synthesis, based on the addition of l-ascorbic acid (l-AA) as a reducing agent, is presented in order to obtain reduced graphene oxide (rGO) and hybrid rGO-MoO2 aerogels for the fabrication of supercapacitors. The resulting high degree of chemical reduction of graphene oxide (GO), confirmed by X-Ray Photoelectron Spectroscopy (XPS) analysis, is shown to produce a better electrical double layer (EDL) capacitance, as shown by cyclic voltammetric (CV) measurements. Moreover, a good reduction yield of the carbonaceous 3D-scaffold seems to be achievable even when the precursor of molybdenum oxide is added to the pristine slurry in order to get the hybrid rGO-MoO2 compound. The pseudocapacitance contribution from the resulting embedded MoO2 microstructures, was then studied by means of CV and electrochemical impedance spectroscopy (EIS). The oxidation state of the molybdenum in the MoO2 particles embedded in the rGO aerogel was deeply studied by means of XPS analysis and valuable information on the electrochemical behavior, according to the involved redox reactions, was obtained. Finally, the increased stability of the aerogels prepared with l-AA, after charge-discharge cycling, was demonstrated and confirmed by means of Field Emission Scanning Electron Microscopy (FESEM) characterization

Application of reverse micelle sol-gel synthesis for bulk doping and heteroatoms Surface Enrichment in Mo-Doped TiO 2 nanoparticles

TiO 2 nanoparticles containing 0.0, 1.0, 5.0, and 10.0 wt.% Mo were prepared by a reverse micelle template assisted sol-gel method allowing the dispersion of Mo atoms in the TiO 2 matrix. Their textural and surface properties were characterized by means of X-ray powder diffraction, micro-Raman spectroscopy, N 2 adsorption/desorption isotherms at -196 °C, energy dispersive X-ray analysis coupled to field emission scanning electron microscopy, X-ray photoelectron spectroscopy, diffuse reflectance UV-Vis spectroscopy, and ζ-potential measurement. The photocatalytic degradation of Rhodamine B (under visible light and low irradiance) in water was used as a test reaction as well. The ensemble of the obtained experimental results was analyzed in order to discover the actual state of Mo in the final materials, showing the occurrence of both bulk doping and Mo surface species, with progressive segregation of MoO x species occurring only at a higher Mo content

Spin-Coated vs. Electrodeposited Mn Oxide Films as Water Oxidation Catalysts

Manganese oxides (MnOx), being active, inexpensive and low-toxicity materials, are considered promising water oxidation catalysts (WOCs). This work reports the preparation and the physico-chemical and electrochemical characterization of spin-coated (SC) films of commercial Mn2O3, Mn3O4 and MnO2 powders. Spin coating consists of few preparation steps and employs green chemicals (i.e., ethanol, acetic acid, polyethylene oxide and water). To the best of our knowledge, this is the first time SC has been used for the preparation of stable powder-based WOCs electrodes. For comparison, MnOx films were also prepared by means of lectrodeposition (ED) and tested under the same conditions, at neutral pH. Particular interest was given to -Mn2O3-based films, since Mn (III) species play a crucial role in the electrocatalytic oxidation of water. To this end, MnO2-based SC and ED films were calcined at 500 C, in order to obtain the desired -Mn2O3 crystalline phase. Electrochemical impedance spectroscopy (EIS) measurements were performed to study both electrode charge transport properties and electrode–electrolyte charge transfer kinetics. Long-term stability tests and oxygen/hydrogen evolution measurements were also made on the highest-performing samples and their faradaic efficiencies were quantified, with results higher than 95% for the Mn2O3 SC film, finally showing that the SC technique proposed here is a simple and reliable method to study the electrocatalytic behavior of pre-synthesized WOCs powders

Spin-Coated vs. Electrodeposited Mn Oxide Films as Water Oxidation Catalysts

Manganese oxides (MnOx), being active, inexpensive and low-toxicity materials, are considered promising water oxidation catalysts (WOCs). This work reports the preparation and the physico-chemical and electrochemical characterization of spin-coated (SC) films of commercial Mn2O3, Mn3O4 and MnO2 powders. Spin coating consists of few preparation steps and employs green chemicals (i.e., ethanol, acetic acid, polyethylene oxide and water). To the best of our knowledge, this is the first time SC has been used for the preparation of stable powder-based WOCs electrodes. For comparison, MnOx films were also prepared by means of lectrodeposition (ED) and tested under the same conditions, at neutral pH. Particular interest was given to -Mn2O3-based films, since Mn (III) species play a crucial role in the electrocatalytic oxidation of water. To this end, MnO2-based SC and ED films were calcined at 500 C, in order to obtain the desired -Mn2O3 crystalline phase. Electrochemical impedance spectroscopy (EIS) measurements were performed to study both electrode charge transport properties and electrode-electrolyte charge transfer kinetics. Long-term stability tests and oxygen/hydrogen evolution measurements were also made on the highest-performing samples and their faradaic efficiencies were quantified, with results higher than 95% for the Mn2O3 SC film, finally showing that the SC technique proposed here is a simple and reliable method to study the electrocatalytic behavior of pre-synthesized WOCs powders

CO2 conversion into hydrocarbons via modified Fischer-Tropsch synthesis by using bulk iron catalysts combined with zeolites

To effectively address the challenges posed by global warming, a prompt and coordinated effort is necessary to conduct an extensive study aimed at reducing CO2 emissions and overcoming the obstacles presented by expensive and scarce fossil fuel resources. This study primarily focuses on comparing two different methodologies for preparing Na-promoted Fe3O4-based catalysts for the CO2 hydrogenation into hydrocarbon mixtures. Three catalysts were synthesized and tested: two samples were impregnated with a different amount of Na (1 wt% and 5 wt%), while a third one was obtained via coprecipitation with NaOH. As the latter catalyst exhibited the best performance, it was combined with zeolites in two ways: physical mixtures and core-shell structures. MFI-type zeolites were used in both configurations and a conventional structure was compared to a hierarchical one. As a result, mesopores increased successfully both the CO2 conversion from 37% to 40% and the liquid hydrocarbon (C6+) selectivity from 29% to 57%, doubling the C6+ yield. On the other hand, NH3-TPD and XPS measurements demonstrated that the intimate contact between the two materials in the core-shell structures led to the migration of Na from the oxide to the zeolite reducing the concentration of strong acid sites and, consequently, the liquid hydrocarbon yield

Switching from Biosimilar to Biosimilar Adalimumab, Including Multiple Switching, in Crohn's Disease: A Prospective Study

No data are available regarding the safety and effectiveness of the biosimilar-to-biosimilar switch of adalimumab in any disease, and in particular in Crohn’s disease (CD). The aim of our study was to provide real world data on switching from biosimilar adalimumab to another biosimilar, including multiple switching. We conducted a prospective, single-centre observational study in which we consecutively recruited all CD patients who switched from adalimumab biosimilar ABP 501 to biosimilar SB5 from January to July 2021. Sixty-one patients were included in the final analysis, of whom 43/61 (70.5%) were multiple switches (Humira(®) → ABP 501 → SB5). After 6 months of follow up, 88.5% (54/61) of patients maintained SB5 on therapy. The success of the switch (defined as no systemic corticosteroids within 6 months, non-discontinuation of SB5, no dose escalation) was achieved by 82.0% (50/61) of patients. At multivariate analysis, C-reactive protein > 5 mg/L predicted switch failure (p = 0.03). Seven patients (11.5%) experienced side effects, compared to one patient (1.6%) in the 6 pre-switch months (p = 0.03). In conclusion, switching from biosimilar to biosimilar of adalimumab did not lead to signs of safety or loss of efficacy other than those already known in the literature for the class of drugs